Archive | European Approval

EMA’s CHMP Recommends Yervoy for Patients 12 and Older with Advanced Melanoma

Yervoy (ipilimumab) has received a positive review by the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP), recommending its approval for the treatment of unresectable or metastatic melanoma in patients age 12 and older.

Read the full story

Posted in Melanoma In The News, European Approval

Breakthrough drug which DOUBLES the survival time for people with deadly melanoma is approved for use on the NHS

A breakthrough drug which uses a man-made virus to treat advanced skin cancer has been approved for use on the NHS.

Read the full story

Posted in Melanoma In The News, European Approval

NICE rejects Roche’s melanoma combo

Patients in England and Wales with a certain type of advanced skin cancer will not be getting routine access to Roche’s Cotellic/Zelboraf combination on the NHS, after it was turned down by the National Institute for Health and Care Excellence.

Read the full story

Posted in Melanoma In The News, European Approval

NICE u-turn in favour of Amgen’s novel melanoma drug

The National Institute for Health and Care Excellence is now recommending NHS use of Amgen’s Imlygic to treat advanced melanoma that has spread and can’t be surgically removed.

Read the full story

Posted in Melanoma In The News, European Approval

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories